Wade D. Miquelon has established himself as a significant figure in the business landscape, particularly in the realms of retail and healthcare. Serving as a director for Acadia Healthcare since January 2012, Miquelon’s extensive experience and strategic insight have positioned him as a key player in the company’s ongoing growth and development.
Currently, Miquelon holds the role of President and Chief Executive Officer of Jo-Ann Stores, LLC, the preeminent fabric and craft specialty retailer in the United States. His leadership at Jo-Ann has been marked by innovative strategies aimed at enhancing customer experience and driving market growth. Miquelon’s tenure at Jo-Ann, as detailed in this profile, is indicative of his ability to adapt and thrive in various retail environments, making him a valuable asset to Acadia Healthcare.
Before his current role, Wade Miquelon served as Executive Vice President, President International, and Chief Financial Officer of Walgreens. His contributions to Walgreens began in June 2008 when he joined the company as Senior Vice President and Chief Financial Officer. During his time with Walgreens, Miquelon played a pivotal role in transforming the financial landscape of the company, steering it through complex challenges until he departed in August 2014, as reported by BizJournals.
Miquelon’s robust resume also includes a prominent stint at Tyson Foods, Inc., where he served as Executive Vice President and Chief Financial Officer from 2006 to 2008. His foundational years were spent at Procter & Gamble Co., where he advanced through various significant roles from 1989 to 2006. Notably, he was the Vice President of Finance for Western Europe, overseeing financial operations across 17 countries. This diverse background has endowed him with a multifaceted perspective on financial management, strategic growth, and international business operations.
The integration of Wade D. Miquelon into Acadia Healthcare’s board reflects a strategic decision to bolster the company’s leadership with expertise that spans both established and emerging markets. Under the chairmanship of Joey Jacobs, the addition of Miquelon is viewed as a powerful move intended to enhance the company’s long-term growth potential. Jacobs expressed confidence in Miquelon’s ability to contribute meaningfully to Acadia’s objectives, stating, “Wade Miquelon brings tremendous expertise in a range of disciplines to Acadia, as well as valuable perspectives from his work with both large established companies and young growth companies.”
Acadia Healthcare, known for its focus on mental health and substance abuse treatment facilities, has seen an impressive 20 percent increase in its stock value since its listing on the Nasdaq in November, with a current market valuation exceeding $300 million, according to MarketScreener. The board’s decision to expand to eight directors, thereby welcoming Miquelon, underscores the dynamic nature of the company as it seeks to navigate the complexities of the healthcare sector.
In summary, Wade D. Miquelon’s extensive background in financial leadership and operational excellence positions him as a vital contributor to Acadia Healthcare’s vision for future growth. His wealth of experience in both retail and healthcare sectors is expected to play a crucial role in enhancing the company’s strategic initiatives as it continues to expand its footprint in the market.